- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01999244
Impact of Self-Monitoring Technology and Interventionist Contact on Weight Loss
21. september 2015 opdateret af: The Miriam Hospital
Despite continued research on effective interventions, obesity remains a major public health issue in the United States.
Current treatments, including behavioral weight management programs, weight loss surgery, and pharmacotherapy, tend to be high in cost and have limited reach, reducing the ability of these treatments to address the population-wide scope of the obesity epidemic.
Recent advances in technology that improve the ease of self-monitoring and provide targeted feedback offer promise to help larger groups of individuals to lose weight.
Despite the commercial popularity of these products, however, little research has been conducted to evaluate their impact on excess body weight or to determine how they should ideally be implemented.
Two key questions need to be addressed.
First, is use of self-monitoring technology sufficient to produce weight loss, or must this technology be combined with interventionist contact?
Second, how cost-effective is a technology-based intervention, with and without interventionist contact?
The current study is small prospective, randomized pilot study comparing a self-guided self-monitoring condition (SC) to a technology only condition (TECH) and a technology plus interventionist support condition (TECH+INT).
All participants will all be given basic weight management information knowledge and randomized to one of three conditions.
Participants in the self-guided self-monitoring condition (SC) will receive traditional paper self-monitoring logs, a standard body weight scale, and a pedometer and calorie book; participants in the technology-based condition (TECH) will receive an electronic activity monitor and WiFi-enabled body weight scale, and will track caloric intake via an associated website; and participants in the interventionist contact condition (TECH+INT) will receive the same technology as in the TECH condition, combined with weekly interventionist contact delivered via telephone.
We will compare the impact of each condition on weight loss and investigate preliminary cost-effectiveness.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
80
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Rhode Island
-
Providence, Rhode Island, Forenede Stater, 02903
- Weight Control & Diabetes Research Center
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 70 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Age between 18 and 70
- BMI between 27 and 40 kg/m2
- Access to a computer and WIFI in the home
Exclusion Criteria:
- Weight over 340 lbs
- Physical limitations that prevent walking 1/4 mile without stopping
- Currently participating in another weight loss program or taking weight loss medication
- Currently pregnant, lactating, less than 6-months post-partum, or plans to become pregnant during the 6-month study period
- Uncontrolled hypertension or diabetes
- History of coronary heart disease
- Terminal Illness
- Plans to relocate during the 6-month study period
- Substance Abuse
- Severe psychiatric disorders
- Dementia
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: SC
Self-guided self-monitoring condition.
Participants will receive standard self-monitoring tools and information on weight regulation.
|
|
|
Eksperimentel: TECH
Technology condition.
Participants will receive self-monitoring technology and information regarding weight regulation.
|
|
|
Eksperimentel: TECH+INT
Technology plus interventionist contact arm.
Participants will receive self-monitoring technology, information regarding weight regulation, and interventionist contact via telephone.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Weight
Tidsramme: 6 months post randomization
|
6 months post randomization
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Kathryn M Ross, PhD MPH, The Miriam Hospital
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Chhabria K, Ross KM, Sacco SJ, Leahey TM. The Assessment of Supportive Accountability in Adults Seeking Obesity Treatment: Psychometric Validation Study. J Med Internet Res. 2020 Jul 28;22(7):e17967. doi: 10.2196/17967.
- Ross KM, Wing RR. Impact of newer self-monitoring technology and brief phone-based intervention on weight loss: A randomized pilot study. Obesity (Silver Spring). 2016 Aug;24(8):1653-9. doi: 10.1002/oby.21536. Epub 2016 Jul 1.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. december 2013
Primær færdiggørelse (Faktiske)
1. juni 2015
Studieafslutning (Faktiske)
1. juni 2015
Datoer for studieregistrering
Først indsendt
25. november 2013
Først indsendt, der opfyldte QC-kriterier
25. november 2013
Først opslået (Skøn)
3. december 2013
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
23. september 2015
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
21. september 2015
Sidst verificeret
1. september 2015
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 209313
- F32DK100069-01 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .